CoChat

Inhibition of progressive reduction of islet β-cell mass in spontaneously diabetic Goto-Kakizaki rats by α-glucosidase inhibitor

The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.

Abstract

The Goto-Kakizaki (GK) rat, an animal model of type 2 diabetes, exhibits mild hyperglycemia with a reduction of beta-cell mass. The mechanism for islet structural changes in this model and whether the changes are affected by metabolic control are not known. In the present study, we examined the process of islet changes in male GK rats aged 6, 8, 12, 24, and 36 weeks. Treatment effects with an alpha-glucosidase inhibitor (Voglibose; Takeda, Osaka, Japan) for 24 weeks (12 to 36 weeks of age) were also evaluated. The beta-cell mass increased until 8 weeks of age in both GK and control rats, but the increase was significantly (P < .01) smaller in GK rats versus at 8 weeks of age. Thereafter, the beta-cell mass decreased in GK rats, whereas it remained constant in controls. Voglibose treatment significantly (P < .01) inhibited the reduction of beta-cell mass in GK rats. Proliferative activity of beta cells as measured by bromodeoxyuridine (BrdU) uptake was significantly (P < .05) lower in GK rats versus control rats at 6 and 8 weeks, but the difference disappeared after 12 weeks of age, regardless of Voglibose treatment. The present study thus demonstrates a progressive loss of beta cells in GK rats that was mitigated by Voglibose treatment. We consider that the beta-cell loss in GK rats was due to an early impairment in proliferative activity and reduced survival. Voglibose did not appear to stimulate beta-cell proliferation, but exerted its effect via a reduction of hyperglycemia.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0026-0495(00)90242-7

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 38 references

Research works printed but not linked: 3

  1. Odaka, 1994, Comparison of the effects of Voglibose (AO-128) and acarbose on postprandial hyperglycemia and intestinal carbohydrate absorption in rats, Jpn Pharmacol Ther, 22, 3491
  2. Lebovitz, 1998, α-Glucosidase inhibitors as agents in the treatment of diabetes, Diabetes Rev, 6, 132
  3. Takami, 1991, Antidiabetic actions of a disaccharidase inhibitor, AO-128, in spontaneously diabetic (GK) rats, Jpn Pharmacol Ther, 19, 4457

Cited by

See all 50

Metadata

Authors
Koyama, M., Wada, R., Mizukami, H., Sakuraba, H., Odaka, H., Ikeda, H., & Yagihashi, S.
Affiliations
Hirosaki University (JP)
Corresponding author
Yagihashi, Soroku
Venue
Metabolism
Publisher
Elsevier BV
Published
2000-03
Volume
49
Issue
3
Pages
347-352
ISSN
0026-0495 (ISSN-L)
OpenAlex
W1970437660
Cited by
50
References
33
Citations by year
2024: 1 · 2022: 2 · 2019: 1 · 2017: 2 · 2016: 1 · 2015: 4 · 2014: 4 · 2013: 1 · 2012: 7
FWCI
2.22
Type
journal article
Language
en
Open access
closed
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)
Locations
  • Metabolism (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
Keywords
Goto-Kakizaki rats, type 2 diabetes, beta-cell mass, beta cell destruction, alpha-glucosidase inhibitors, voglibose, beta-cell proliferation, hyperglycemia, islet structure, beta-cell survival
MeSH terms
Aging, Animals, Body Weight, Diabetes Mellitus, Type 2, Enzyme Inhibitors, Inositol, Islets of Langerhans, Male, Rats, Mutant Strains, Rats, Wistar, Rats, Glycoside Hydrolase Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Inhibition of progressive reduction of islet β-cell mass in spontaneously diabetic Goto-Kakizaki rats by α-glucosidase inhibitor. https://app.cochat.ai/papers/10.1016/s0026-0495(00)90242-7
The paper
Koyama, M., Wada, R., Mizukami, H., Sakuraba, H., Odaka, H., Ikeda, H., & Yagihashi, S. (2000). Inhibition of progressive reduction of islet β-cell mass in spontaneously diabetic Goto-Kakizaki rats by α-glucosidase inhibitor. Metabolism. https://doi.org/10.1016/s0026-0495(00)90242-7

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.